OCALA, Fla., Feb. 17, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple ...
The MarketWatch News Department was not involved in the creation of this content. New York, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that John F.
SAN DIEGO, Calif. — Team members with the U.S. Army Medical Materiel Development Activity joined thousands of biotechnology industry experts from across the world for the Biotechnology Innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results